Legal & General Group Plc

Position in DTIL — Precision Biosciences Inc

CIK 764068 London, X0

Position in DTIL

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$18,353

+$12,669 QoQ

Shares Held

2,335

+1499.3% QoQ

Ownership

0.008%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#70

of 94 holders

Holding Since

Mar 2020

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Legal & General Group Plc holds $3,286,710,193 across 292 Biotechnology names. DTIL ranks #250 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	1,870,015	$928,892,550
2	REGN	Regeneron Pharmaceuticals, Inc.	759,971	$473,872,316
3	ALNY	Alnylam Pharmaceuticals, Inc.	924,561	$278,320,596
4	RPRX	Royalty Pharma plc	3,800,504	$213,094,258
5	INCY	Incyte Corp	1,605,980	$182,053,892
6	ARGX	Argenx SE	177,164	$164,367,443
7	INSM	INSMED Inc	826,431	$88,114,072
8	RVMD	Revolution Medicines, Inc.	381,366	$71,422,223

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$18,353	2,335	-46.6%	Shares	Defined	2026-08-14
2022-09-30	$5,684	4,373	-93.4%	Shares	Defined	2022-11-14
2022-06-30	$105,807	66,130	+144.1%	Shares	Defined	2022-08-22
2022-03-31	$83,427	27,087	0.0%	Shares	Defined	2022-05-16
2021-12-31	$200,442	27,087	+0.4%	Shares	Defined	2022-02-14
2021-09-30	$311,290	26,975	+52.6%	Shares	Defined	2021-11-15
2021-06-30	$221,252	17,672	+177.0%	Shares	Defined	2021-08-12
2021-03-31	$66,032	6,380	-8.0%	Shares	Defined	2021-05-17
2020-12-31	$57,837	6,935	+23.2%	Shares	Defined	2021-02-12
2020-09-30	$34,680	5,630	-24.1%	Shares	Defined	2020-11-13
2020-06-30	$61,783	7,417	+24.8%	Shares	Defined	2020-08-14
2020-03-31	$35,836	5,943	—	Shares	Defined	2020-05-14
No filing history on record for this holder in this stock.